Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 April 2019 | Story Ruan Bruwer | Photo Varsity Cup
Lubabalo Dobela
Flyhalf Lubabalo Dobela will be an important cog in the wheel for the Shimlas against the Maties in the semi-final stage of the Varsity Cup. He has been named Player that Rocks twice this year.

The Shimlas (University of the Free State) will go into the semi-final against the unbeaten Maties with confidence, knowing that they can compete against them, said coach Hendro Scholtz.

The Shimlas will travel to Stellenbosch for the Varsity Cup clash on Monday (8 April). They qualified for the play-offs thanks to a 38-14 victory over the University of Johannesburg (UJ) in the final round of the competition on Monday 1 April 2019.

The Free State students lost to the Maties by 59-14 two weeks ago, and although the score reflects a big hiding, the Shimlas stood tall for most of the encounter.

“With 18 minutes remaining, we trailed by only ten points (14-24). We can gain confidence from that. We learned a couple of things about them. We will have to stop their driving mall and be sharp when it comes to our discipline. They will hurt us if we concede penalties,” said Scholtz.

According to him, it is important to get off to a good start. “You often sit with students who have other things to think about apart from rugby, such as upcoming tests, which can hamper their concentration. Against UJ in the wet, it was important to play the conditions right, and I think it made the players concentrate that little bit more.”

The Shimlas won four of their eight group matches and will look back on their defeats against the Pukke and Ixias as matches that they could easily have won on another day.

It is the fifth time in the 12 years of the Varsity Cup that the Shimlas have reached the final-four stage, with one win in 2015 over the Ikeys.

The Shimlas will be without two of their key men among the forwards – the injured flank Janco Cloete and hooker Hanno Snyman.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept